Modular high-throughput platform for the purification of scFvs and multispecific antibody-based therapeutics

Bastian Franke1, Julien Québatte1, Sebastian Wolniak1

  • 1Numab Therapeutics AG, Bachtobelstrasse 5, 8810 Horgen, Switzerland.

PubMed
Abstract

Related Concept Videos